Data / Form D filings / Ibex Biosciences, Inc.
Ibex Biosciences, Inc.: Form D filings
Ibex Biosciences, Inc., a biotechnology company in Rockville, MD, filed 4 Form D notices with the SEC between 2020 and 2025. The latest, on February 20, 2025, reports $70,000 sold of a $12.5 million offering to 3 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 9610 Medical Center Drive, Rockville, MD, 20850
- Phone
- (301) 761-1500
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 1798553
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 20, 2025 | New notice | $12,500,000 | $70,000 | $12,430,000 | 3 | Feb 5, 2025 | sec.gov |
| Jul 15, 2021 | New notice | $5,000,000 | $1,000,000 | $4,000,000 | 2 | Jul 5, 2021 | sec.gov |
| Jan 2, 2020 | New notice | $2,400,000 | $2,400,000 | 15 | Sep 25, 2018 | sec.gov | |
| Jan 2, 2020 | New notice | $2,400,000 | $1,765,000 | $635,000 | 6 | Aug 15, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Roy Joseph Feinson | Director | |
| Alberto Murat Croci | Executive Officer, Director | |
| Michael Joseph Karlin | Executive Officer, Director | |
| Sylvan Isaac Karlin | Director |
Other biotechnology companies in Maryland that filed recently
- Accufy Diagnostics, Inc. $2 million · Oct 28, 2026
- OS Therapies Inc $7.2 million · Oct 23, 2026
- Kaigene, Inc. $55 million · Oct 14, 2026
- Templar Nova, Inc. $7 million · Oct 7, 2026
- Monocacy Therapeutics Inc. $25,000 · Oct 7, 2026
- Seraxis Holdings, Inc. $10 million · Sep 24, 2026
Every Form D from the week of Feb 17, 2025 · All recent filings in Maryland · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Ibex Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.